Neural Galaxy, also known as Galaxy Brain Scientific, develops precision non-invasive neuromodulation technologies for neurological and psychiatric disorders. The company is based in Beijing and centers its platform on individualized brain functional mapping, with clinical programs spanning autism, depression, Parkinson’s disease, Alzheimer’s disease, and post-stroke recovery.

Its pBFS platform maps patient-specific brain functional sectors and identifies circuit targets for stimulation. Public materials describe a Precision Circuit Stimulation System and POINT Therapy approach that combines functional mapping, neural decoding, and targeted iTBS-based stimulation.

Neural Galaxy works through clinical research and hospital-linked deployment pathways in China. Its role on the map is as a precision neuromodulation developer using individualized functional mapping to make non-invasive stimulation more circuit-specific across multiple brain-disorder indications.